BridgeMD
New treatment option for Newborn Screening
Official title Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project
ClinicalTrials.gov ID: NCT06549218
What this study is testing
- What it's testing
- The main objective of the genetic newborn screening part of the Screen4Care-project is to shorten the path to rare disease diagnosis and to facilitate early intervention. Therefore, genetic newborn screening for currently treatable rare diseases (TREAT-panel approach) will be offered to families expecting a baby.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 2. Healthy volunteers may be eligible.
You may be able to join if
- TREAT-panel:
- newborns
- Infants born in one of the participating hospitals and birth centres
- Informed consent signed by both parents/legal guardian to participate in genetic newborn screening (TREAT-panel)
- Whole genome sequencing:
You likely can't join if
- Missing informed consent of parents/legal guardian
See the full eligibility criteria
- TREAT-panel:
- newborns
- Infants born in one of the participating hospitals and birth centres
- Informed consent signed by both parents/legal guardian to participate in genetic newborn screening (TREAT-panel)
- Whole genome sequencing:
- Participation in the TREAT-panel study
- Symptoms suggestive of a genetic disease within the first 2 years of life
- Informed consent signed by both parents/legal guardian to participate in genetic newborn screening (TREAT-panel) and the whole genome sequencing
- Missing informed consent of parents/legal guardian
The study team makes the final eligibility decision.
Where it's taking place
- Dijon, France
- Berlin, Germany
- Freiburg im Breisgau, Germany
- Göttingen, Germany
- Rome, Lazio, Italy
- Ferrara, Italy
- Modena, Italy
- Roma, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 2 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dijon, France; Berlin, Germany; Freiburg im Breisgau, Germany; Göttingen, Germany; Rome, Lazio, Italy; Ferrara, Italy and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.